Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Clioquinol for Otomycosis: A Lesser Understood Antimicrobial.

Cimolai N.

Otol Neurotol. 2020 Jan;41(1):141-142. doi: 10.1097/MAO.0000000000002513. No abstract available.

PMID:
31834186
2.

Does oral vancomycin use necessitate therapeutic drug monitoring?

Cimolai N.

Infection. 2019 Nov 11. doi: 10.1007/s15010-019-01374-7. [Epub ahead of print] Review.

PMID:
31713055
3.

Dilemmas in the recognition of Sjögren syndrome.

Cimolai N.

CMAJ. 2019 Oct 7;191(40):E1110. doi: 10.1503/cmaj.73159. No abstract available.

PMID:
31591101
4.

Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.

Cimolai N.

Clin Med Res. 2019 Dec;17(3-4):90-96. doi: 10.3121/cmr.2019.1486. Epub 2019 Aug 28.

5.

Potential toxicity of topical ocular solutions.

Cimolai N.

CMAJ. 2019 Aug 12;191(32):E898. doi: 10.1503/cmaj.72457. No abstract available.

PMID:
31405839
6.

Are Clostridium difficile toxins nephrotoxic?

Cimolai N.

Med Hypotheses. 2019 May;126:4-8. doi: 10.1016/j.mehy.2019.03.002. Epub 2019 Mar 5.

PMID:
31010497
7.

Acetazolamide and Cardiac Failure.

Cimolai N.

Clin Drug Investig. 2018 Jul;38(7):649-650. doi: 10.1007/s40261-018-0653-1. No abstract available.

PMID:
29736885
8.

Night terrors associated with celiac disease.

Cimolai N.

Eur J Gastroenterol Hepatol. 2018 Jun;30(6):687-688. doi: 10.1097/MEG.0000000000001098. No abstract available.

PMID:
29697525
9.

Cyclical hypervirulent S aureus clones and community-acquired MRSA infection.

Cimolai N.

Can Fam Physician. 2017 Dec;63(12):917. No abstract available.

10.

Fish processing and human infection.

Cimolai N.

CMAJ. 2017 Nov 13;189(45):E1400. doi: 10.1503/cmaj.733359. No abstract available.

11.

Zopiclone overdose and flumazenil rescue.

Cimolai N.

CMAJ. 2017 Apr 24;189(16):E613. doi: 10.1503/cmaj.732933. No abstract available.

12.

Animal visitation in acute care medical facilities.

Cimolai N.

CMAJ. 2015 Nov 3;187(16):1236. doi: 10.1503/cmaj.1150070. No abstract available.

13.

Penicillin VK oral suspension.

Cimolai N.

CMAJ. 2015 Apr 7;187(6):439. doi: 10.1503/cmaj.115-0025. No abstract available.

14.

Influenza vaccine efficacy.

Cimolai N.

CMAJ. 2015 Apr 7;187(6):438. doi: 10.1503/cmaj.115-0021. No abstract available.

15.

The Canadian contribution to the science of verotoxigenic Escherichia coli and associated illnesses: the early years.

Cimolai N.

Can J Microbiol. 2013 Nov;59(11):709-15. doi: 10.1139/cjm-2013-0644. Epub 2013 Oct 29.

16.

The potential and promise of mefenamic acid.

Cimolai N.

Expert Rev Clin Pharmacol. 2013 May;6(3):289-305. doi: 10.1586/ecp.13.15. Review.

PMID:
23656341
17.

Otitis from the common bedbug.

Cimolai N, Cimolai TL.

J Clin Aesthet Dermatol. 2012 Dec;5(12):43-5.

18.

Yohimbine use for physical enhancement and its potential toxicity.

Cimolai N, Cimolai T.

J Diet Suppl. 2011 Dec;8(4):346-54. doi: 10.3109/19390211.2011.615806. Epub 2011 Oct 21. Review.

PMID:
22432773
19.

Chronic multifocal osteomyelitis: is infectious causation a moot point?

Cimolai N.

J Infect Public Health. 2011 Sep;4(4):157-68. doi: 10.1016/j.jiph.2011.05.001. Review.

20.

Methicillin-resistant Staphylococcus aureus in Canada: a historical perspective and lessons learned.

Cimolai N.

Can J Microbiol. 2010 Feb;56(2):89-120. doi: 10.1139/w09-109. Review.

PMID:
20237572
21.

The severity of H1N1.

Cimolai N.

CMAJ. 2010 Mar 9;182(4):384. doi: 10.1503/cmaj.110-2024. No abstract available.

22.

Cyclobenzaprine: a new look at an old pharmacological agent.

Cimolai N.

Expert Rev Clin Pharmacol. 2009 May;2(3):255-63. doi: 10.1586/ecp.09.5.

PMID:
24410704
23.

Erythromelalgia accompanying rosuvastatin-associated myopathy.

Cimolai N, Cimolai T.

J Dermatol Case Rep. 2009 Apr 5;3(1):1-3. doi: 10.3315/jdcr.2009.1026.

24.
25.

Comparison of commercial and in-house immunoblot assays for the rapid diagnosis of Mycoplasma pneumoniae infection.

Cimolai N.

J Infect Chemother. 2008 Feb;14(1):75-6. doi: 10.1007/s10156-007-0580-1. Epub 2008 Feb 24. No abstract available.

PMID:
18297456
26.

MRSA and the environment: implications for comprehensive control measures.

Cimolai N.

Eur J Clin Microbiol Infect Dis. 2008 Jul;27(7):481-93. doi: 10.1007/s10096-008-0471-0. Epub 2008 Feb 14. Review.

PMID:
18273652
27.

Socks but no gloves.

Cimolai N.

Eur J Clin Microbiol Infect Dis. 2008 May;27(5):395-6. doi: 10.1007/s10096-007-0444-8. Epub 2008 Jan 9.

PMID:
18183438
28.

Severe iron deficiency anemia and gastrointestinal dysfunction associated with ingestion of pan masala.

Cimolai N, Cimolai T.

J Diet Suppl. 2008;5(3):305-9. doi: 10.1080/19390210802414352.

PMID:
22432465
29.

The role of healthcare personnel in the maintenance and spread of methicillin-resistant Staphylococcus aureus.

Cimolai N.

J Infect Public Health. 2008;1(2):78-100. doi: 10.1016/j.jiph.2008.10.001. Epub 2008 Nov 18. Review.

30.

Infections in the natural environment of British Columbia, Canada.

Cimolai N, Cimolai T.

J Infect Public Health. 2008;1(1):11-26. doi: 10.1016/j.jiph.2008.08.003. Epub 2008 Oct 27. Review.

31.

Zopiclone: is it a pharmacologic agent for abuse?

Cimolai N.

Can Fam Physician. 2007 Dec;53(12):2124-9.

32.

The cranberry and the urinary tract.

Cimolai N, Cimolai T.

Eur J Clin Microbiol Infect Dis. 2007 Nov;26(11):767-76. Review.

PMID:
17694340
33.

Methicillin-resistant Staphylococcus aureus public concern, and legislative mandates.

Cimolai N.

Infect Control Hosp Epidemiol. 2007 Jul;28(7):896. No abstract available.

PMID:
17674465
34.

Nitrofurantoin and pregnancy.

Cimolai N, Cimolai T.

CMAJ. 2007 Jun 19;176(13):1860-1. No abstract available.

35.

MRSA control and the counter-culture.

Cimolai N.

J Hosp Infect. 2007 Jun;66(2):189-90. Epub 2007 May 18. No abstract available.

PMID:
17512632
36.

Corticosteroids and complicated Mycoplasma pneumoniae infection.

Cimolai N.

Pediatr Pulmonol. 2006 Oct;41(10):1008-9; author reply 1010. No abstract available.

PMID:
16871631
37.
38.

Treatment of Shiga-like toxin-producing Escherichia coli infection.

Cimolai N.

Clin Infect Dis. 2006 Jun 15;42(12):1804-5. No abstract available.

PMID:
16705590
39.

Staphylococcus aureus outbreaks among newborns: new frontiers in an old dilemma.

Cimolai N.

Am J Perinatol. 2003 Apr;20(3):125-36. Review.

PMID:
12802712
40.

Nonhemolytic Streptococcus pyogenes causing invasive infection.

Cimolai N, Trombley C, Bhanju NM.

Clin Pediatr (Phila). 2002 Jul-Aug;41(6):453. No abstract available.

PMID:
12166801
41.

Are all MRSA made equal?

Cimolai N.

Can J Microbiol. 2002 Jun;48(6):560-6. Review.

PMID:
12166684
42.

Anti-Mycoplasma pneumoniae secretory antibody in human breast milk.

Macadam S, Cimolai N.

Diagn Microbiol Infect Dis. 2002 Jul;43(3):247-50.

PMID:
12106960
43.
44.

Candida dubliniensis fungemia and vascular access infection.

Cimolai N, Davis J, Trombley C.

J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):237-9.

PMID:
11990315
45.

Do mycoplasmas cause human cancer?

Cimolai N.

Can J Microbiol. 2001 Aug;47(8):691-7. Review.

PMID:
11575494
46.

Molecular diagnostics confirm the paucity of parapertussis activity.

Cimolai N, Trombley C.

Eur J Pediatr. 2001 Aug;160(8):518. No abstract available.

PMID:
11548193
47.

Utilization of herpes simplex PCR assays for cerebrospinal fluid in a pediatric health care setting.

Cimolai N, Thomas EE, Tan R, Hill A.

Can J Microbiol. 2001 May;47(5):392-6.

PMID:
11400728
48.

Escherichia coli infections and hemolytic-uremic syndrome.

Cimolai N.

CMAJ. 2001 May 15;164(10):1405-6. No abstract available.

49.

Bartonella henselae infection in British Columbia: evidence for an endemic disease among humans.

Cimolai N, Benoit L, Hill A, Lyons C.

Can J Microbiol. 2000 Oct;46(10):908-12.

PMID:
11068677
50.

Nosocomial transmission of penicillin-resistant Streptococcus pneumoniae.

Cimolai N, Cogswell A, Hunter R.

Pediatr Pulmonol. 1999 Jun;27(6):432-4.

PMID:
10380097

Supplemental Content

Loading ...
Support Center